Apple's R&D spend is $10B+, 6.8% of revenue in 2016, up from 2.6% of revenue in 2013, hinting at major new products, pivot from iPhone-dependent business model
People are focusing on the wrong thing when analyzing Apple's path forward in the face of slowing iPhone sales.
Context & Ripple Effects
This piece lands a week after Above Avalon argued that a slowing iPhone upgrade cycle would keep sales growth from recovering — so the question it answers is what Apple does with its cash when the core product stops compounding. Its answer: the R&D line, which jumped from 2.6% of revenue in 2013 to 6.8% on more than $10B in 2016.
The trajectory held. By early 2018 analysts were projecting ~$14B in annual R&D, nearly double in four years and a 14-year high as a share of revenue, and by mid-2019 quarterly spending hit 7.9% of revenue. A decade later the same metric reads 10.3% of revenue amid the AI boom — making this 2016 analysis the opening data point of a sustained repositioning rather than a one-off spike.
First-order effects
- Apple is absorbing a shrinking share of growth from iPhone unit sales while directing an ever-larger slice of revenue into R&D — the immediate trade-off is margin discipline versus bets on products beyond the phone.
Second-order effects
- Services becomes the offsetting pillar while hardware matures: the following year's results showed services revenue at $7.04B, up 18% YoY, even as iPhone and iPad units slipped — giving Apple a second engine to fund the R&D ramp.
Third-order effects
- If the pattern holds, R&D intensity stops being cyclical and becomes structural: a company that spent 2.6% of revenue on research in 2013 now spends four times that share, meaning future product categories — not annual iPhone refreshes — carry the growth case.
The trend: Apple's R&D intensity has climbed almost continuously since 2013, converting the post-iPhone-peak anxiety of 2016 into a decade-long structural shift toward research-led diversification.